Marketing-Sales Alignment & Enablement Questions

Diagnostic plan (overview): split into quick quantitative audit, targeted qualitative research, and coordinated marketing & sales checks to find where value/expectation breaks.

1. Quantitative diagnosis (analytics, 3–5 days)

• Funnel drill-down: cohort sign-up source, landing page, UTM, device, geography, signup timestamp.
• Post-signup behavior: activation steps completed, time-to-first-value (TTFV), feature usage, trial engagement heatmaps.
• Segmentation: traffic channel, plan intent (free vs trial), company size, persona.
• Instrumentation check: verify events, experiment flags, billing hooks for lost at-paywall.

2. Qualitative diagnosis (1–2 weeks, parallel)

• Rapid user interviews (10–15 recent sign-ups who didn’t convert) with sales/CS join for context. Focus: expectation at signup, friction points, perceived value.
• Support and sales transcripts review: common objections, pricing, feature requests.
• Usability test of onboarding and billing flow (5–8 users) to spot UX blockers.

3. Marketing & Sales alignment

• Review acquisition messaging vs product experience for mismatch.
• Check trial qualification: are low-intent leads (promos, incentives) being driven?
• Sales outreach: validate lead quality, demo conversion rates, follow-up cadence.

Three experiments

Experiment A — Onboarding simplification + TTFV optimization

• Change: deliver a 3-step guided onboarding that gets users to one core value metric in <10 minutes (checklist + inline tips + sample data).
• Expected outcome: higher activation and trial engagement.
• Success criteria: 25% uplift in users reaching activation within 24h; 15% lift in trial-to-paid in variant vs control (stat sig, p<0.05) over 4 weeks.

Experiment B — Pricing transparency & trial-to-paid nudges

• Change: show clear pricing and billing info pre-trial end + in-app countdown, and one-click upgrade from product with prorated billing.
• Expected outcome: reduces sticker shock and increases conversions from ready users.
• Success criteria: reduce churn at trial end by 30%; increase paid conversions by 10% within 2 weeks of trial end.

Experiment C — Qualified trial gating + sales assist for high-value leads

• Change: add lightweight qualification (company size/use-case) at signup; auto-route high-value trials to SDR for a personalized onboarding/demo.
• Expected outcome: improves conversion for high-LTV segments and optimizes sales resources.
• Success criteria: high-value cohort trial-to-paid increases by 20%; CAC for that cohort stays flat or decreases.

Implementation notes:

• Run A/B tests, track primary metrics (trial→paid), secondary (activation, NPS, time-to-value).
• Minimum detectable effect and sample-size calc before launch.
• Stop/iterate rules: if no uplift in 2 weeks and sample sufficient, roll back and use qualitative feedback to pivot.

This plan balances quick wins (onboarding, nudges) and structural fixes (lead quality, pricing alignment) while tying experiments to measurable success.

Approach summary: validate willingness-to-pay (WTP) with mixed qualitative + quantitative experiments, propose three testable pricing hypotheses, run pilots and conversion experiments, then model simple ARR forecasts per hypothesis.

Validate price sensitivity

• Customer interviews (20 target mid-market buyers) using Van Westendorp + Gabor-Granger to elicit acceptable price ranges and feature-value mapping.
• A/B pricing tests on pilot cohorts and landing pages (multi-armed funnels) to measure conversion and upgrade rates.
• Usage telemetry + sales CRM: track trial-to-paid conversion by segment and price, and willingness to negotiate.

Three pricing hypotheses (mid-market: 100–2,500 employees)

1. Per-seat premium: $15/user/month with annual billing; expected ARPA $9k/year for average 50-seat buyer.
2. Tiered flat-per-account: Starter $1,500/mo, Growth $3,500/mo, Enterprise $8,000/mo (all annualized) — simplifies procurement and increases deal size.
3. Hybrid: Base platform $1,000/mo + $5/user/mo over 50 seats — balances predictability and scale.

Experiments to validate

• Landing-page A/B test: show price variants + CTA with gated demo; measure MQL rate and demo-to-trial conversion.
• Prototype quotes in live sales cycles (randomized by SDR): offer one of the three pricing options and track close rate, time-to-close, discount given.
• Gabor-Granger survey to estimate purchase probability at price points; pilot 3-month discount promos to measure churn/resilience.

First-year ARR forecasts (simple model; 12-month)
Assumptions common: 500 target accounts reached via GTM, 5% qualified conversion to paid across funnels baseline, average contract length 1 year, CAC baked into GTM.

1. Per-seat ($15/user/mo)

• Avg seats per customer: 50 => ARR/customer = 501512 = $9,000
• Conversion rate: 5% => customers = 25
• ARR = 25 * $9,000 = $225,000

2. Tiered flat

• Mix: 60% Starter, 30% Growth, 10% Enterprise
• ARR/customer = weighted avg = 0.618k +0.342k +0.1*96k = $33,600
• Conversion rate: 4% (higher friction) => customers = 20
• ARR = 20 * $33,600 = $672,000

3. Hybrid

• Avg seats 80 (mid-market skew), ARR/customer = 1,000*12 + (80-50)512 = 12,000 + 1,800 = $13,800
• Conversion rate: 4.5% => customers = 22.5 ~22
• ARR = 22 * $13,800 = $303,600

Use these as priors; iterate pricing after experiments, track CAC payback and churn. Recommend running 8–12 week experiments, then select approach that maximizes ARR per reachable account while meeting target LTV:CAC and sales efficiency.

Play Definition:
A consultative-selling play for our predictive analytics capability that positions the product as a decision-enablement layer — not a feature. Sales will diagnose a customer's decision pain, quantify value uplift using a quick ROI framing, and propose a phased proof-of-value (PoV) that demonstrates predictive insights integrated into an existing workflow (pilot -> scale).

Ideal Customer Profile (ICP):

• Industry: Financial services, retail, logistics, or healthcare with high-frequency operational decisions
• ARR: $50M+ and >$5M annual spend in the target domain
• Data maturity: Centralized data warehouse or lake, basic ETL, >1 year of historical operational data
• Champion: Head of Analytics, Ops Leader, or VP of Revenue who owns process KPIs
• Pain signals: frequent manual forecasting, >10% decision reversal rate, regulatory/efficiency drivers

Sample Discovery Script (10–15 min):

• Open: “Quick context — we help teams predict X outcome to reduce Y cost. Can I ask a few questions about your current process?”
• Problem: “Walk me through the decision you make weekly/day-to-day around [target use case]. Who’s involved and what tools do you use?”
• Impact: “How often do those decisions miss the mark? What’s the typical cost (time, revenue, compliance) when they do?”
• Data: “Where does the historical data live? How many months/rows and who owns access?”
• Constraints: “What would block a pilot? Security, integrations, stakeholder buy-in?”
• Close: “If we could show a 10–20% improvement in [metric] in a 6–8 week pilot, would you be open to a short technical assessment?”

Three KPIs to track (quarter):

1. Pipeline conversion rate for PoV-qualified opportunities (% of discovery → signed PoV) — measures play effectiveness.
2. Average projected ROI per PoV (estimated monthly savings OR revenue uplift) — measures quality of ICP targeting and value framing.
3. PoV-to-production velocity (median weeks from PoV start to production decision) — measures technical fit and operational buy-in.

Notes for enablement: provide battlecards, ROI calculator template, one-page technical checklist, and 60-minute coach-the-coach sessions with sales + solutions engineers.

Account-based marketing (ABM) targets a defined set of high-value accounts with personalized campaigns instead of broad demand-generation. It requires tight product-marketing-sales alignment so messaging, value props, and buying motions match account needs and sales outreach.

Alignment needed:

• Marketing: builds tailored content, campaigns, and measurement for named accounts.
• Sales: owns account engagement, provides input on ICP and feedback loops.
• Product: supplies product differentiators, use cases, pilot offers, and telemetry to prove fit.

When a PM should advocate ABM:

• When average deal size, lifetime value, or strategic importance justify personalized effort.
• When sales cycles are long, complex, and decision-makers are few.

Product signals validating ABM:

• High concentration of revenue in top accounts (Pareto/80-20).
• Clear ICP segments with similar pain points and buying committees.
• Strong product-qualified-account (PQA) signals: enterprise usage patterns, multi-seat adoption, pilot requests, feature adoption by decision roles.
• Predictable expansion paths and measurable ROI from early targeted pilots.

If these hold, prioritize ABM; otherwise continue broad acquisition.

First 30 days — early signal and QA

• Activation rate (users who try the paid feature / eligible users): detects discoverability and onboarding friction. If low → improve in-product prompts, tooltips, or reduce steps to try.
• Conversion to trial/purchase (free→paid trial or upgrade): immediate revenue signal; low conversion suggests pricing, value messaging, or perceived ROI issues — run A/B on messaging & CTA placement.
• Feature usage depth & frequency (DAU/WAU for feature, key actions per session): shows whether users find value. Low engagement → simplify core flows, highlight value moments.
• Errors & support tickets related to the feature: surface UX/deployment bugs to fix fast.

First 60 days — adoption and retention

• Paid retention / churn (cohort retention for purchasers): tells if value sustains. Early drop → investigate onboarding, time-to-value and add guided experiences.
• Time-to-first-value (TTFV): how long until users experience benefit; long TTFV → add quick-start templates or in-app guidance.
• Trial-to-paid conversion rate & reasons for drop-offs (qualitative feedback + exit surveys): informs product improvements or pricing adjustments.
• Customer acquisition cost (CAC) by channel for the paid feature: ensures GTM efficiency; high CAC → reallocate budget or optimize creatives/landing pages.

First 90 days — scale and business impact

• MRR / ARR and ARPU (average revenue per user) for feature: revenue impact and segmenting by plan to inform packaging.
• LTV:CAC ratio for feature cohorts: long-term viability; low ratio → revisit pricing, retention levers, or upsell motions.
• NPS / satisfaction for paying users and feature-specific CSAT: product-market fit signals; low scores trigger roadmap prioritization for improvements.
• Expansion metrics (upsell, cross-sell rate) and referral rate: indicate viral/monetizable hooks to amplify.

How I use signals to iterate:

• Combine quantitative cohorts with qualitative interviews to diagnose root causes.
• Prioritize fixes that shorten TTFV, increase activation, and reduce churn (impact × effort).
• Run rapid A/B tests on onboarding, messaging, and pricing; monitor cohorts over 30/60/90 days before scaling spend.
• Feed learnings to GTM: refine target segments, creatives, and sales enablement based on who gets value fastest.

These metrics move from immediate health/quality (30d) to growth/efficiency (60d) to revenue scalability and strategic decisions (90d).